Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celastrol effects on interleukin-8 production and NF-kB activation in human monocytes
TCTR20190422002Completed
- Sponsor
- Thammasat University
- Start
- May 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of celastrol, sponsored by Thammasat University. Primary endpoint: Anti-inflammatory effect of celastrol. Started May 2019; status: completed.
02
Drugs
celastrol
Beyond the preview
Go deeper on TCTR20190422002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190422002.